Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$100.62
+2.14%
Mkt Cap $6.74B
Analyst Ratings
Buy
16
Hold
1
Sell
0
Price Target (16 analysts)
$116.75
Range $108.00 – $121.00
Implied Upside
+16.0%
Consensus $116.75 vs current $100.62